# Basal Like Bladder Cancer : Signature and Therapeutic

> **NCT02648100** · — · UNKNOWN · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 911 (estimated)

## Conditions studied

- Muscle Invasive Bladder Cancer
- Molecular Taxonomy

## Interventions

- **OTHER:** biomarker study

## Key facts

- **NCT ID:** NCT02648100
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-03
- **Primary completion:** 2019-12
- **Final completion:** 2019-12
- **Target enrollment:** 911 (ESTIMATED)
- **Last updated:** 2017-06-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02648100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02648100, "Basal Like Bladder Cancer : Signature and Therapeutic". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02648100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*